Andrew N. Ginn
- Molecular Medicine top 1%
- Ecology top 10%
- Infectious Diseases top 10%
- Epidemiology
- Molecular Biology
- Co-authors
- Jonathan R. IredellSally R. PartridgeLee ThomasAgnieszka M. WiklendtHeather F. GiddingShereen ShomaMuhammad KamruzzamanTom Olma
- Topics
- Antibiotic Resistance in Bacteria (20 papers)Bacterial Identification and Susceptibility Testing (9 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)
- Partner nations
- AustraliaUnited StatesChina
In The Last Decade
Andrew N. Ginn
36 papers receiving 901 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 392
- Ecology 212
- Infectious Diseases 204
- Epidemiology 201
- Molecular Biology 190
Countries citing papers authored by Andrew N. Ginn
This map shows the geographic impact of Andrew N. Ginn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew N. Ginn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew N. Ginn more than expected).
Fields of papers citing papers by Andrew N. Ginn
This network shows the impact of papers produced by Andrew N. Ginn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew N. Ginn. The network helps show where Andrew N. Ginn may publish in the future.
Co-authorship network of co-authors of Andrew N. Ginn
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew N. Ginn. A scholar is included among the top collaborators of Andrew N. Ginn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew N. Ginn. Andrew N. Ginn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 15 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 8 | |
| 9 | 15 | |
| 10 | 4 | |
| 11 | 28 | |
| 12 | 46 | |
| 13 | 11 | |
| 14 | 9 | |
| 15 | 25 | |
| 16 | 79 | |
| 17 | 85 | |
| 18 | 130 | |
| 19 | 21 | |
| 20 | 14 |
About Andrew N. Ginn
Andrew N. Ginn is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 38 papers that have together received 917 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (20 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Molecular Medicine (392 citations), Endocrinology (167 citations) and Applied Microbiology and Biotechnology (43 citations). Andrew N. Ginn has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Jonathan R. Iredell, Sally R. Partridge, Lee Thomas, Agnieszka M. Wiklendt, Heather F. Gidding, Shereen Shoma, Muhammad Kamruzzaman, Tom Olma, Ian T. Paulsen and B. Dillon. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.